Viragen Reports Advancement in Avian Transgenics Biomanufacturing
Anti-cancer Antibody Expressed in Rooster
21-Feb-2005 -
Viragen, Inc. announced an advancement in its program to develop avian transgenic biomanufacturing for the purpose of using chickens as bioreactors for the efficient and economical production of human pharmaceutical protein-based drugs in their eggs.
Viragen, in collaboration with Roslin ...
bioreactors
melanoma
Oxford BioMedica
+1